Ecogen Inc. said Wednesday that it has signed a five-yearagreement with Pfizer Inc. under which Pfizer willmanufacture Ecogen's Bacillus thuringiensis-containingbiopesticides. The companies previously had a two-yearagreement. Pfizer produces all of Ecogen's requirements for itsBt products in the United States and abroad at a facility inTerre Haute, Ind. Shares of Langhorne, Pa.-based Ecogen(NASDAQ:EECN) closed at $14.38, up $1.25.
(c) 1997 American Health Consultants. All rights reserved.